Trusted by:
In a new study published in Clinical Trials, researchers led by Stephen Juraschek, MD, PhD (Medicine, BIDMC) compared four electronic-based and four traditional recruitment methods for clinical trials to determine how different strategies may impact enrollment of groups traditionally under-represented in the medical literature.
The COVID-19 pandemic has fundamentally disrupted U.S. healthcare organizations.
In a new study from Beth Israel Deaconess Medical Center (BIDMC), researchers analyzed data from the National Center for Health Statistics to compare the rate of cardiovascular-related deaths before and after the onset of the pandemic in the United States, relative to the same periods in the prior year.
In a new study led by an interdisciplinary team of gerontologists, geriatricians, precision medicine experts, and bioinformaticians at Beth Israel Deaconess Medical Center (BIDMC), researchers identified a single protein present in the blood that is associated with increased risk of post-operative delirium.
A team of researchers at Beth Israel Deaconess Medical Center (BIDMC) has developed a mathematical means of assessing tests鈥� false-negative rate.
A study led by Beth Israel Deaconess Medical Center physician-researchers provides new, much-needed data about the optimal physical distancing between students for the prevention of COVID-19 in the school setting.
The team at Beth Israel Deaconess Medical Center demonstrated that COVID-19 cases resulted in significantly more weekly hospitalizations, more use of mechanical ventilation and higher mortality rates than influenza.
In a research letter written by colleagues at Beth Israel Deaconess Medical Center (BIDMC) and published in the Journal of the American College of Cardiology, the authors report racial disparities improved only minimally in rural areas over the last two decades, with larger improvements occurring in urban areas.
In a randomized clinical trial published in the journal PAIN, researchers found participants with moderate to severe irritable bowel syndrome (IBS) who were knowingly treated with a pharmacologically inactive pill 鈥� referred to as an honest or open-label placebo 鈥� reported clinically meaningful improvements in their IBS symptoms.
Study reveals that, while mother-to-newborn transmission of the virus is rare, newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks as a result of worsening maternal COVID-19 illness.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right